IRIS UniCatt

Sora', Federica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.630
AS - Asia 4.786
EU - Europa 4.229
SA - Sud America 962
Continente sconosciuto - Info sul continente non disponibili 381
AF - Africa 138
OC - Oceania 11
Totale 17.137
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.386
SG - Singapore 2.132
DE - Germania 1.180
CN - Cina 1.148
IT - Italia 916
BR - Brasile 785
SE - Svezia 587
VN - Vietnam 427
FR - Francia 395
GB - Regno Unito 246
IN - India 195
IE - Irlanda 193
FI - Finlandia 171
UA - Ucraina 171
ID - Indonesia 145
BD - Bangladesh 129
JP - Giappone 126
HK - Hong Kong 103
RU - Federazione Russa 101
CA - Canada 96
TR - Turchia 70
KR - Corea 66
MX - Messico 60
AR - Argentina 53
NL - Olanda 50
IQ - Iraq 45
PL - Polonia 32
AT - Austria 31
CO - Colombia 29
ES - Italia 28
EC - Ecuador 27
SA - Arabia Saudita 27
CI - Costa d'Avorio 26
BE - Belgio 22
MA - Marocco 22
UZ - Uzbekistan 22
ZA - Sudafrica 22
VE - Venezuela 21
IR - Iran 20
CZ - Repubblica Ceca 18
CL - Cile 17
EG - Egitto 17
CR - Costa Rica 15
KE - Kenya 15
CH - Svizzera 13
PH - Filippine 13
PK - Pakistan 13
AZ - Azerbaigian 12
AE - Emirati Arabi Uniti 11
HN - Honduras 11
JO - Giordania 11
LT - Lituania 11
AL - Albania 10
JM - Giamaica 10
NP - Nepal 10
GT - Guatemala 9
HU - Ungheria 9
PE - Perù 9
IL - Israele 8
PY - Paraguay 8
UY - Uruguay 8
AU - Australia 7
DZ - Algeria 7
MY - Malesia 7
RO - Romania 7
SV - El Salvador 7
TN - Tunisia 7
TT - Trinidad e Tobago 7
ET - Etiopia 6
LB - Libano 6
PA - Panama 6
TH - Thailandia 6
BG - Bulgaria 5
EE - Estonia 5
OM - Oman 5
PR - Porto Rico 5
SN - Senegal 5
TW - Taiwan 5
AO - Angola 4
BZ - Belize 4
DO - Repubblica Dominicana 4
KZ - Kazakistan 4
NO - Norvegia 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BB - Barbados 3
GE - Georgia 3
GR - Grecia 3
IS - Islanda 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BO - Bolivia 2
GY - Guiana 2
HR - Croazia 2
KG - Kirghizistan 2
LI - Liechtenstein 2
LK - Sri Lanka 2
LV - Lettonia 2
MD - Moldavia 2
Totale 16.728
Salva come PNG Salva come JPEG
Città #
Singapore 1.137
Ashburn 775
San Jose 700
Chandler 506
Beijing 232
Rome 191
Dublin 189
Hefei 174
Woodbridge 174
Los Angeles 159
Ho Chi Minh City 136
Lauterbourg 136
Jacksonville 127
Milan 127
Jakarta 126
Tokyo 119
Hanoi 114
San Mateo 113
New York 109
Munich 99
Dearborn 98
Hong Kong 96
Houston 95
Wilmington 93
Chicago 92
Nanjing 88
Frankfurt am Main 87
Fairfield 83
Council Bluffs 79
Hyderabad 79
Santa Clara 79
Helsinki 76
Tukwila 70
The Dalles 68
Dallas 63
Florence 61
Seattle 61
Seoul 60
St Louis 60
Moscow 56
Boston 54
Cattolica 54
Redmond 54
São Paulo 54
Buffalo 52
Nürnberg 52
Kent 50
Princeton 49
Ann Arbor 48
Atlanta 44
Redwood City 44
Nanchang 43
Marseille 42
Lappeenranta 41
Boardman 37
Paris 37
Orem 33
Bremen 31
London 31
Lancaster 30
Lawrence 30
Toronto 30
Izmir 28
Phoenix 28
Abidjan 26
Nuremberg 26
Rio de Janeiro 26
Shanghai 26
Brooklyn 23
Warsaw 23
Belo Horizonte 22
Brussels 22
Kunming 22
Mexico City 22
Philadelphia 22
San Francisco 22
Da Nang 21
Denver 20
Guangzhou 20
Naples 19
Amsterdam 18
Dhaka 18
Montreal 18
Norwalk 18
Stockholm 18
Tashkent 18
Turku 18
Manchester 17
Tianjin 17
Baghdad 16
Cambridge 16
Haiphong 16
Porto Alegre 16
Pune 16
Curitiba 15
Düsseldorf 15
Poplar 15
Salvador 15
Bologna 14
Chennai 14
Totale 8.673
Salva come PNG Salva come JPEG
Nome #
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 441
Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis 391
Dasatinib first-line: Multicentric Italian experience outside clinical trials 297
Dasatinib first-line: Multicentric Italian experience outside clinical trials 297
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 295
Correlation between paraproteinaemia and viral reactivation after allo-SCT 230
Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients 229
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 215
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 189
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 182
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia 179
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 178
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 176
A Multicenter Real-life Prospective Study of Axicabtagene Ciloleucel versus Tisagenlecleucel Toxicity and Outcomes in Large B-cell Lymphomas 175
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab. 168
Immune recovery after low-dose Campath therapy in a group of pretreated patients affected by B-cell chronic lymphocytic leukemia [9] 166
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 165
EXTREME THROMBOCYTOSIS IN CHRONIC MYELOID LEUKEMIA IN THE ERA OF TYROSINE KINASE INHIBITORS 164
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration 159
revalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience. 156
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 155
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 154
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 153
H1N1 Influenza among Hematological Patients: Monocentric Influenza Cases from 2011 to 2016 151
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 151
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 143
Guillain-Barre' syndrome following Varicella zoster reactivation in Chronic Lymphocytic Leukemia treated with fludarabine 142
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 142
Acute graft versus host disease 1976-2020: reduced incidence and predictive factors 139
Non-tunnelled central venous catheters in adult stem cell transplantation recipients: an effective option 139
High-dose glucocorticoids plus Ofatumumab in fludarabine/alemtuzumab-resistant B-cell chronic lymphocytic leukemia 139
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors. A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (Gitmo) 137
Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib: 10-year followup of the GIMEMA CML 0307 study 136
Pure red cell aplasia among ABO mismatched hematopoietic stem cell transplant recipients: a 13-years retrospective study and literature review 136
Donor cell-derived myelofibrosis relapse after allogeneic stem cell transplantation 134
Subcutaneous immunoglobulins in chronic lymphocytic leukemia with secondary antibody deficiency. A monocentric experience during Covid-19 pandemics 134
Allogeneic hematopoietic stem cell transplantation in therapy-related myeloid neoplasms (t-MN) of the adult: Monocentric observational study and review of the literature 133
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 131
Unselected donor-derived hematopoietic stem cells boost for Chimeric Antigen Receptor T-cell associated hematotoxicity 130
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 128
CAR-T treatment is safe and effective in adult patients with Down syndrome and B-cell acute lymphoblastic leukemia (B-ALL) 125
Inflammation and acute cardiotoxicity in adult hematological patients treated with CAR-T cells: results from a pilot proof-of-concept study 124
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 124
Age influences initial dose and compliance to imatinib in chronic myeloid leukemia elderly patients but concomitant comorbidities appear to influence overall and event-free survival 123
Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience 122
The impact of donor-specific antibodies’ presence on the outcome post-allogeneic hematopoietic stem cell transplantation: a survey from a single center 119
Unlocking Predictive Power: Quantitative Assessment of CAR-T Expansion with Digital Droplet Polymerase Chain Reaction (ddPCR) 118
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 117
Risk factors for hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation in a letermovir-exposed CMV-free population receiving PTCy 117
Effect of HLA mismatch on post-transplant infections in allogeneic hematopoietic stem cell transplantation with PTCy-based GvHD prophylaxis 115
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All-Trans Retinoic Acid: A Monocentric Experience 115
CAR-T from cord blood in a patient with Ph+ acute lymphoblastic leukemia relapsing after hematopoietic stem cell transplantation 115
Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers 114
The CD4/CD8 ratio of infused CD19-CAR-T is a prognostic factor for efficacy and toxicity 113
Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: Effects on response rate, toxicity and outcome 112
Second haploidentical stem cell transplantation for primary graft failure 111
Day +60 WT1 assessment on CD34 selected bone marrow better predicts relapse and mortality after allogeneic stem cell transplantation in acute myeloid leukemia patients 110
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-t Cells 110
Imatinib in very elderly patients with chronic myeloid leukemia in chronic phase: a retrospective study 110
Haploidentical bone marrow transplantation for AML in remission following TBF conditioning: a long-term follow up 110
Coagulopathy in CAR-T: Critical concern or mere blip? 109
Chlorambucil PLUS Rituximab As FRONT-LINE THERAPY in Elderly or Unfit Patients Affected by B-CELL Chronic Lymphocytic Leukemia: Results of A Single-Centre Retrospective Analysis 109
Eltrombopag for the treatment of poor graft function following allogeneic stem cell transplant: a retrospective multicenter study 109
Baseline Tumor Burden Assessed With AI-Guided PET/CT Total Metabolic Tumor Volume (TMTV) and LDH Levels Predict Efficacy of CAR-T in Aggressive B-Cell Lymphoma 108
Post-transplant cyclophosphamide with Sirolimus or Cyclosporine for GvHD prophylaxis in matched related and unrelated transplantation: a two-center analysis on 213 consecutive patients 106
Allogeneic Hemopoietic Stem Cell Transplants in Patients with Acute Myeloid Leukemia (AML) Prepared with Busulfan and Fludarabine (BUFLU) or Thiotepa, Busulfan, and Fludarabine (TBF): A Retrospective Study 106
Triple post transplant cyclophosphamide (PTCY) based GVHD prophylaxis: HLA matched versus HLA haploidentical transplants. 104
Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study 103
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 101
Unrelated cord blood transplantation and post-transplant cyclophosphamide 101
Vascular inflammation in patients undergoing anti-CD19 chimeric antigen receptor-T cells for haematologic malignancies: a call for cardiovascular surveillance 100
Next-generation sequencing improves BCR-ABL1 mutation detection in Philadelphia chromosome -positive acute lymphoblastic leukemia 100
Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience 100
Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline 99
Impact of SARS-CoV-2 vaccination and passive prophylaxis with tixagevimab/cilgavimab on CAR-T patients: a three-year regional experience from the Italian covid pandemic 98
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All-Trans Retinoic Acid: A Monocentric Experience 98
Successful management of chronic disseminated candidiasis in hematologic patients treated with high-dose liposomal amphotericin B: a retrospective study of the SEIFEM registry 98
Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice. 98
allogenic hemopoietic stem cell transplant in patients with acute myeloid leukemia prepared with busulfan and fludarabine or thiotepa busulfan and fludarabine a retrospective study 98
Autoimmune hemolytic anemia in chronic lymphocytic leukemia: A comprehensive review 98
Dasatinib is safe and effective in unselected chronic myeloid leukaemia elderly patients resistant/intolerant to imatinib 97
Chronic myeloid leukaemia with extreme thrombocytosis at presentation: Incidence, clinical findings and outcome 96
Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience 96
Treatment patterns in patients with chronic-phase chronic myeloid leukaemia in routine clinical practice: The simplicity Italian population 96
The concomitance of lymphoma and breast carcinoma in the bone 95
Days alive outside hospital and readmissions in patients undergoing allogeneic transplants from identical siblings or alternative donors 95
basutinibin the real-life treatment of chronic myeloid leukemia patients aged 65 years resistant intolerant to previous tyrosine kinase inhibitors 94
Allogeneic stem cell transplantation for blast crisis chronic myeloid leukemia in the era of tyrosine kinase inhibitors - A retrospective study by the EBMT Chronic Malignancies Working Party 94
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 93
Residual peripheral Blood CD26+ leukemic stem cells in chronic myeloid leukemia patients during TKI therapy and durin treatment- free Remission 93
Impact of Covid 19 pandemic on hematopoietic stem cell transplantation activities: Report from a single center 92
Autologous peripheral blood stem cell transplantation and the role of lenalidomide in patients affected by poems syndrome 92
VEGF and IL-6 Correlation in POEMS: A Potential Upcoming Marker of Active Disease and Early Autologous BMT Response 92
correction idelalisib exposure before allogenic stem cell transplantation in patients with follicular lymphoma an EBMT survey 91
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T) 91
Hammersmith score application identifies chronic myeloid leukemia patients with poor prognosis before treatment with second-generation tyrosine kinase inhibitors 90
Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors 90
Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice. 90
Graft versus host disease in unmanipulated haploidentical marrow transplantation with a modified post-transplant cyclophosphamide (PT-CY) regimen: an update on 425 patients 89
treatment free remission in chronic myeloid leukemia fron-line with nilotinib 10 year followup of GIMEMA CML 0307 study 87
Totale 13.479
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.050
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.050
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022636 0 0 27 32 54 20 16 115 35 52 144 141
2022/20231.604 198 193 110 199 154 211 74 125 205 43 71 21
2023/20241.068 38 272 57 76 37 117 86 71 21 58 98 137
2024/20252.782 83 69 179 161 206 104 104 112 355 269 653 487
2025/20266.324 900 214 408 640 917 355 1.047 378 449 520 289 207
2026/20271.566 572 688 306 0 0 0 0 0 0 0 0 0
Totale 17.137